SCHEMBL6276852

SCHEMBL6276852

CC(C)(C)NC(=O)C(C)(C)N(OC(c1ccccc1)c1ccccc1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
KMT2A Q03164 3/20 0.37
LMNA P02545 3/20 0.37
MEN1 O00255 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
EGFR P00533 1/20 0.35
ATM Q13315 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP2C9 P11712 1/20 0.34
EPHX1 P07099 1/20 0.34
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CNR1 P21554 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12862758 0.75 TSHR (0.43) MAPTKMT2ALMNAHDAC3HDAC1
SCHEMBL6283397 0.74 MAPT (0.42) MAPTKMT2ALMNAMEN1HDAC3
SCHEMBL10334738 0.67 MAPT (0.55) MAPTKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL6276844 0.67 MAPT (0.42) MAPTKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL12862755 0.66 EPHX1 (0.31) EPHX1
SCHEMBL6276849 0.65 KMT2A (0.39) MAPTKMT2ALMNAMEN1ATM
SCHEMBL13911917 0.64 HDAC3 (0.59) MAPTKMT2AMEN1HDAC3HDAC1
SCHEMBL10688938 0.64 LMNA (0.54) MAPTKMT2ALMNAMEN1HDAC3
SCHEMBL12669776 0.64 LMNA (0.54) MAPTKMT2ALMNAMEN1HDAC3
SCHEMBL12669773 0.64 LMNA (0.54) MAPTKMT2ALMNAMEN1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6841703-B2 Open chain alkoxyamine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-01-11 US disclosed
EP-1100772-B1 OPEN CHAIN ALKOXYAMINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS CIBA SC HOLDING AG (CH) 2004-04-14 EP disclosed
US-20030125489-A1 Open chain alkoxyamine compounds and their use as polymerization regulators NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6518326-B1 Open chain alkoxyamine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORPORATION 2003-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125489-A1 Open chain alkoxyamine compounds and their use as polymerization regulators ALOX5, PTGER1, ALOX12 MAPT 3566/4885KMT2A 2491/4885LMNA 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.